Literature DB >> 30170079

Rhubarb Peony Decoction ameliorates ulcerative colitis in mice by regulating gut microbiota to restoring Th17/Treg balance.

Shuang Luo1, Ruyan Wen2, Qing Wang1, Zhongxiang Zhao1, Feifei Nong1, Yajun Fu1, Shaowei Huang1, Jinyan Chen3, Lian Zhou4, Xia Luo5.   

Abstract

ETHNOPHARMACOLOGY RELEVANCE: Rhubarb Peony Decoction (RPD) is a formula of traditional Chinese medicine chronicled in Jin Gui Yao Lve, commonly used to treat ulcerative colitis (UC). However, the underlying mechanism of RPD treating UC remains elusive. In our study, we investigated the therapeutic efficacy of RPD and potential mechanism involved in inhibiting dextran sulfate sodium (DSS)-induced ulcerative colitis in mice.
METHODS: The colitis was induced by DSS in mice for 5 days and estimated body weight loss, disease activity index (DAI) and colon length. Histological changes were observed by H&E staining. The number and abundance of gut mircrobiota were measured with 16 S rDNA sequencing. GC-MS was used to detect the concentration of short chain fatty acids (SCFAs) in cecum. Flow cytometry analyzed the proportion of Th17 and Treg cells in mesenteric lymph nodes (MLNs). IL-17A and Foxp3 in colon were determined by immunohistochemical analyses. The level of cytokine was determined by Multi-Analyte Flow Assay Kit.
RESULTS: Administration of RPD significantly alleviated the pathological changes of UC mice, involving rescued the inflammation-related reduction of colon length, ameliorated body weight loss and damaged tissue. In addition, RPD altered the gut microbiota, involving restored α diversity, increased significantly the abundance of Firmicutes and Actinobacteria, decreased the Proteobacteria and Bacteroidetes. Furthermore, the number of Butyricicoccus pullicaecorum, a butyrate-producing bacterium, were augmented obviously by RPD. Besides, RPD restored the content of SCFA in intestinal tract. Additionally, the proportion of Th17 cells and Treg cells in mesenteric lymph nodes, likewise, the expression of IL-17A and Foxp3 in colon were regulated by RPD, contributing to the restoration of Th17/Treg balance. Moreover, RPD significantly decreased the level of IL-6, TNF-α, IFNγ, IL-10, IL-17A, IL-21, IL-22 in colon, simultaneously increased Treg-related cytokine TGF-β at dose-dependently.
CONCLUSIONS: These results demonstrated that RPD had effect on ulcerative colitis, which was related to regulating gut microbiota, especially Butyricicoccus pullicaecorum, and SCFAs to restore the gut Th17/Treg homeostasis.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Butyricicoccus pullicaecorum; Gut microbiota; Rhubarb Peony Decoction; SCFAs; Th17/Treg; Ulcerative colitis

Mesh:

Substances:

Year:  2018        PMID: 30170079     DOI: 10.1016/j.jep.2018.08.033

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  32 in total

1.  Efficacy of faecal microbiota transplantation on ulcerative colitis and its effect on gastrointestinal motility and immune function.

Authors:  Dengshun Lei; Hong Xu; Renqun Peng; Mei Yang; Xinghui Li; Wei Zuo; Juhua Gou; Shuangjiang Yu; Min Huang; Hao Liu
Journal:  Am J Transl Res       Date:  2021-12-15       Impact factor: 4.060

2.  Rhubarb Alleviates Acute Lung Injury by Modulating Gut Microbiota Dysbiosis in Mice.

Authors:  Tingyu Tang; Fei Wang; Juan Liu; Wu Ye; Tian Zhao; Zhijun Li
Journal:  Curr Microbiol       Date:  2022-02-26       Impact factor: 2.188

3.  5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism.

Authors:  Ling Huang; Junping Zheng; Guangjun Sun; Huabing Yang; Xiongjie Sun; Xiaowei Yao; Aizhen Lin; Hongtao Liu
Journal:  Cell Mol Life Sci       Date:  2022-08-01       Impact factor: 9.207

Review 4.  Inflammatory bowel disease: an overview of Chinese herbal medicine formula-based treatment.

Authors:  Shuo Yuan; Qi Wang; Jiao Li; Jia-Chen Xue; You Li; Huan Meng; Xiao-Ting Hou; Ji-Xing Nan; Qing-Gao Zhang
Journal:  Chin Med       Date:  2022-06-18       Impact factor: 4.546

5.  Shaoyao-Gancao Decoction Ameliorates the Inflammation State in Polycystic Ovary Syndrome Rats via Remodeling Gut Microbiota and Suppressing the TLR4/NF-κB Pathway.

Authors:  Zhuang-Peng Chang; Gui-Feng Deng; Yun-Yun Shao; Ding Xu; Yi-Nan Zhao; Yi-Fan Sun; Shi-Quan Zhang; Rui-Gang Hou; Jun-Jin Liu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

6.  Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis.

Authors:  Leichang Zhang; Xiaofei Ma; Peng Liu; Wei Ge; Lixia Hu; Zhengyun Zuo; Huirong Xiao; Wu Liao
Journal:  Exp Biol Med (Maywood)       Date:  2021-04-29

7.  Gu-Ben-Fang-Xiao Decoction Ameliorated Murine Asthma in Remission Stage by Modulating Microbiota-Acetate-Tregs Axis.

Authors:  Yingmei Dong; Hua Yan; Xia Zhao; Rui Lin; Lili Lin; Yuanyuan Ding; Liwei Liu; Lishun Ren; Qiongqiong Xing; Jianjian Ji
Journal:  Front Pharmacol       Date:  2020-05-04       Impact factor: 5.810

8.  Effects of soy milk consumption on gut microbiota, inflammatory markers, and disease severity in patients with ulcerative colitis: a study protocol for a randomized clinical trial.

Authors:  Omid Sadeghi; Alireza Milajerdi; Seyed Davar Siadat; Seyed Ali Keshavarz; Ali Reza Sima; Homayoon Vahedi; Peyman Adibi; Ahmad Esmaillzadeh
Journal:  Trials       Date:  2020-06-23       Impact factor: 2.279

9.  Chlorogenic Acid Attenuates Dextran Sodium Sulfate-Induced Ulcerative Colitis in Mice through MAPK/ERK/JNK Pathway.

Authors:  Wenyan Gao; Changhong Wang; Li Yu; Tianjiao Sheng; Zhuolin Wu; Xiaoqian Wang; Dongqi Zhang; Yifan Lin; Yang Gong
Journal:  Biomed Res Int       Date:  2019-04-18       Impact factor: 3.411

Review 10.  Regulation of the intestinal microbiota: An emerging therapeutic strategy for inflammatory bowel disease.

Authors:  Bei Yue; Zhi-Lun Yu; Cheng Lv; Xiao-Long Geng; Zheng-Tao Wang; Wei Dou
Journal:  World J Gastroenterol       Date:  2020-08-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.